Alteration of lncRNA RHPN1-AS1 predicts clinical prognosis and regulates the progression of bladder cancer via modulating miR-485-5p.

Jingmin ZhouJinshan XuLin ChengShuhui LiDeqi JiangJianchao ZhangYulong Sheng

Published in: The International journal of biological markers (2024)

RHPN1-AS1 serves as a prognostic biomarker and tumor promoter in bladder cancer via modulating miR-485-5p, which might be a reliable target of bladder cancer therapy.